---
title: "BMRN SEC Filings and Financial Statements | Tradytics"
description: "Annual income statements, balance sheets and cash flows for BioMarin Pharmaceuticals (BMRN), with links to the SEC filings."
url: "https://tradytics.com/research/BMRN/fundamentals"
image: "https://tradytics.com/api/v2/og/research.png?id=BMRN&v=stock-11994868"
---

# BMRN financial statements and SEC filings

## BMRN annual income statement

| Fiscal period end | Revenue | Operating income | Net income | SEC filing |
| --- | --- | --- | --- | --- |
| 2025-12-31 | $3.22B | $409.48M | $348.90M | [10-K](https://www.sec.gov/Archives/edgar/data/1048477/000104847726000004/0001048477-26-000004-index.htm) |
| 2024-12-31 | $2.85B | $484.21M | $426.86M | [10-K](https://www.sec.gov/Archives/edgar/data/1048477/000104847726000004/0001048477-26-000004-index.htm) |
| 2023-12-31 | $2.42B | $185.77M | $167.65M | [10-K](https://www.sec.gov/Archives/edgar/data/1048477/000104847726000004/0001048477-26-000004-index.htm) |
| 2022-12-31 | $2.10B | $160.97M | $141.56M | [10-K](https://www.sec.gov/Archives/edgar/data/1048477/000104847725000007/0001048477-25-000007-index.htm) |
| 2021-12-31 | $1.85B | -$82.34M | -$64.08M | [10-K](https://www.sec.gov/Archives/edgar/data/1048477/000104847724000016/0001048477-24-000016-index.htm) |
| 2020-12-31 | $1.86B | -$43.44M | $854.03M | [10-K](https://www.sec.gov/Archives/edgar/data/1048477/000104847723000009/0001048477-23-000009-index.htm) |

## BMRN annual balance sheet

| Fiscal period end | Assets | Liabilities | Equity | SEC filing |
| --- | --- | --- | --- | --- |
| 2025-12-31 | $7.59B | $1.51B | $6.09B | [10-Q](https://www.sec.gov/Archives/edgar/data/1048477/000104847726000023/0001048477-26-000023-index.htm) |
| 2024-12-31 | $6.99B | $1.33B | $5.66B | [10-K](https://www.sec.gov/Archives/edgar/data/1048477/000104847726000004/0001048477-26-000004-index.htm) |
| 2023-12-31 | $6.84B | $1.89B | $4.95B | [10-K](https://www.sec.gov/Archives/edgar/data/1048477/000104847725000007/0001048477-25-000007-index.htm) |
| 2022-12-31 | $6.38B | $1.77B | $4.60B | [10-K](https://www.sec.gov/Archives/edgar/data/1048477/000104847724000016/0001048477-24-000016-index.htm) |
| 2021-12-31 | $6.00B | $1.74B | $4.27B | [10-K](https://www.sec.gov/Archives/edgar/data/1048477/000104847723000009/0001048477-23-000009-index.htm) |
| 2020-12-31 | $5.85B | $1.74B | $4.11B | [10-K](https://www.sec.gov/Archives/edgar/data/1048477/000104847722000012/0001048477-22-000012-index.htm) |

## BMRN annual cash flow

| Fiscal period end | Operating cash flow | Capital expenditure | Financing cash flow | SEC filing |
| --- | --- | --- | --- | --- |
| 2025-12-31 | $827.99M | -$103.04M | -$42.39M | [10-K](https://www.sec.gov/Archives/edgar/data/1048477/000104847726000004/0001048477-26-000004-index.htm) |
| 2024-12-31 | $572.84M | -$85.42M | -$526.45M | [10-K](https://www.sec.gov/Archives/edgar/data/1048477/000104847726000004/0001048477-26-000004-index.htm) |
| 2023-12-31 | $159.26M | -$96.69M | -$18.73M | [10-K](https://www.sec.gov/Archives/edgar/data/1048477/000104847726000004/0001048477-26-000004-index.htm) |
| 2022-12-31 | $175.90M | -$120.96M | -$18.65M | [10-K](https://www.sec.gov/Archives/edgar/data/1048477/000104847725000007/0001048477-25-000007-index.htm) |
| 2021-12-31 | $304.54M | -$95.58M | -$48.00K | [10-K](https://www.sec.gov/Archives/edgar/data/1048477/000104847724000016/0001048477-24-000016-index.htm) |
| 2020-12-31 | $85.36M | -$114.31M | $181.12M | [10-K](https://www.sec.gov/Archives/edgar/data/1048477/000104847723000009/0001048477-23-000009-index.htm) |

- [BMRN stock research](https://tradytics.com/research/BMRN)
- [BMRN financial summary](https://tradytics.com/research/BMRN/financials)
- [Read the data without JavaScript](https://tradytics.com/research/BMRN/fundamentals?snapshot=1)
